Page 69 - NobleCon21

DocGo Inc.

SELECTED FINANCIAL ITEMS DCGO
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 120.83 96.03 80.42 70.81 368.09
Gross Profit 40.50 30.85 25.42 18.13 114.89
Gross Margin 34% 32% 32% 26% 31%
EBIT (7.47) (14.00) (17.48) (25.24) (64.19)
EBIT Margin -6% -15% -22% -36% -17%
Net Income to Common Shareholders (7.65) (11.08) (13.29) (29.66) (61.67)
Net Margin -6% -12% -17% -42% -17%

Balance Sheet Key Items
Total Assets 455.62 430.79 408.26 353.78 353.78
Cash & Short Term Investments 89.24 79.01 104.16 73.36 73.36
% of Assets 20% 18% 26% 21% 21%
Current Assets -Total 304.49 262.53 236.57 190.23 190.23
% of Assets 67% 61% 58% 54% 54%
Total Liabilities 140.44 128.87 120.53 93.12 93.12
% of Assets 31% 30% 30% 26% 26%
Current Liabilities - Total 121.81 107.57 100.15 73.58 73.58
% of Assets 27% 25% 25% 21% 21%
Long Term Debt 0.01 0.00 NA 0.20 0.20
% of Assets 0% 0% NM 0% 0%
Total Equity 315.18 301.92 287.73 260.66 260.66
% of Assets 69% 70% 70% 74% 74%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 12.89 9.66 33.60 1.66 57.81
Net Cash Flow - Investing (5.57) (5.73) (21.38) 1.10 (31.58)
Net Cash Flow - Financing (7.86) (8.52) (7.38) (33.05) (56.81)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference